256 related articles for article (PubMed ID: 32878024)
1. Classification of Thyroid Tumors Based on Mass Spectrometry Imaging of Tissue Microarrays; a Single-Pixel Approach.
Kurczyk A; Gawin M; Chekan M; Wilk A; Łakomiec K; Mrukwa G; Frątczak K; Polanska J; Fujarewicz K; Pietrowska M; Widlak P
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878024
[TBL] [Abstract][Full Text] [Related]
2. Peptide Profile Differences of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features, Encapsulated Follicular Variant, and Classical Papillary Thyroid Carcinoma: An Application of Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging.
Ucal Y; Tokat F; Duren M; Ince U; Ozpinar A
Thyroid; 2019 Aug; 29(8):1125-1137. PubMed ID: 31064269
[No Abstract] [Full Text] [Related]
3. Molecular profiles of thyroid cancer subtypes: Classification based on features of tissue revealed by mass spectrometry imaging.
Pietrowska M; Diehl HC; Mrukwa G; Kalinowska-Herok M; Gawin M; Chekan M; Elm J; Drazek G; Krawczyk A; Lange D; Meyer HE; Polanska J; Henkel C; Widlak P
Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):837-845. PubMed ID: 27760391
[TBL] [Abstract][Full Text] [Related]
4. Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging.
Smith A; Galli M; Piga I; Denti V; Stella M; Chinello C; Fusco N; Leni D; Manzoni M; Roversi G; Garancini M; Pincelli AI; Cimino V; Capitoli G; Magni F; Pagni F
J Proteomics; 2019 Jan; 191():114-123. PubMed ID: 29581064
[TBL] [Abstract][Full Text] [Related]
5. Imaging mass spectrometry in papillary thyroid carcinoma for the identification and validation of biomarker proteins.
Min KW; Bang JY; Kim KP; Kim WS; Lee SH; Shanta SR; Lee JH; Hong JH; Lim SD; Yoo YB; Na CH
J Korean Med Sci; 2014 Jul; 29(7):934-40. PubMed ID: 25045225
[TBL] [Abstract][Full Text] [Related]
6. Proteomics for the diagnosis of thyroid lesions: preliminary report.
Pagni F; Mainini V; Garancini M; Bono F; Vanzati A; Giardini V; Scardilli M; Goffredo P; Smith AJ; Galli M; De Sio G; Magni F
Cytopathology; 2015 Oct; 26(5):318-24. PubMed ID: 25040579
[TBL] [Abstract][Full Text] [Related]
7. Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions.
Pagni F; De Sio G; Garancini M; Scardilli M; Chinello C; Smith AJ; Bono F; Leni D; Magni F
Proteomics; 2016 Jun; 16(11-12):1775-84. PubMed ID: 27029406
[TBL] [Abstract][Full Text] [Related]
8. Molecular Heterogeneity of Papillary Thyroid Cancer: Comparison of Primary Tumors and Synchronous Metastases in Regional Lymph Nodes by Mass Spectrometry Imaging.
Gawin M; Kurczyk A; Stobiecka E; Frątczak K; Polańska J; Pietrowska M; Widłak P
Endocr Pathol; 2019 Dec; 30(4):250-261. PubMed ID: 31664609
[TBL] [Abstract][Full Text] [Related]
9. Proteome profiles of different types of thyroid cancers.
Gawin M; Wojakowska A; Pietrowska M; Marczak Ł; Chekan M; Jelonek K; Lange D; Jaksik R; Gruca A; Widłak P
Mol Cell Endocrinol; 2018 Sep; 472():68-79. PubMed ID: 29183805
[TBL] [Abstract][Full Text] [Related]
10. PD-L1 and thyroid cytology: A possible diagnostic and prognostic marker.
Dell'Aquila M; Granitto A; Martini M; Capodimonti S; Cocomazzi A; Musarra T; Fiorentino V; Pontecorvi A; Lombardi CP; Fadda G; Pantanowitz L; Larocca LM; Rossi ED
Cancer Cytopathol; 2020 Mar; 128(3):177-189. PubMed ID: 31821747
[TBL] [Abstract][Full Text] [Related]
11. Detection of metabolites discriminating subtypes of thyroid cancer: Molecular profiling of FFPE samples using the GC/MS approach.
Wojakowska A; Chekan M; Marczak Ł; Polanski K; Lange D; Pietrowska M; Widlak P
Mol Cell Endocrinol; 2015 Dec; 417():149-57. PubMed ID: 26415588
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of S100C in thyroid lesions.
Torres-Cabala C; Panizo-Santos A; Krutzsch HC; Barazi H; Namba M; Sakaguchi M; Roberts DD; Merino MJ
Int J Surg Pathol; 2004 Apr; 12(2):107-15. PubMed ID: 15173915
[TBL] [Abstract][Full Text] [Related]
13. Proteomic profiling of follicular and papillary thyroid tumors.
Sofiadis A; Becker S; Hellman U; Hultin-Rosenberg L; Dinets A; Hulchiy M; Zedenius J; Wallin G; Foukakis T; Höög A; Auer G; Lehtiö J; Larsson C
Eur J Endocrinol; 2012 Apr; 166(4):657-67. PubMed ID: 22275472
[TBL] [Abstract][Full Text] [Related]
14. [Cytokeratin expression of benign and malignant epithelial thyroid gland tumors. An immunohistologic study of 154 neoplasms using 8 different monoclonal cytokeratin antibodies].
Schröder S; Wodzynski A; Padberg B
Pathologe; 1996 Nov; 17(6):425-32. PubMed ID: 9082363
[TBL] [Abstract][Full Text] [Related]
15. DNA microarray and miRNA analyses reinforce the classification of follicular thyroid tumors.
Jacques C; Guillotin D; Fontaine JF; Franc B; Mirebeau-Prunier D; Fleury A; Malthiery Y; Savagner F
J Clin Endocrinol Metab; 2013 May; 98(5):E981-9. PubMed ID: 23569218
[TBL] [Abstract][Full Text] [Related]
16. MALDI-MSI Analysis of Cytological Smears: The Study of Thyroid Cancer.
Mosele N; Smith A; Galli M; Pagni F; Magni F
Methods Mol Biol; 2017; 1618():37-47. PubMed ID: 28523498
[TBL] [Abstract][Full Text] [Related]
17. Expression of RET in follicular cell-derived tumors of the thyroid gland: prevalence and implication of morphological type.
Inaba M; Umemura S; Satoh H; Abe Y; Kurokawa K; Sakai H; Osamura RY
Pathol Int; 2003 Mar; 53(3):146-53. PubMed ID: 12608895
[TBL] [Abstract][Full Text] [Related]
18. Discrimination of normal oral mucosa from oral cancer by mass spectrometry imaging of proteins and lipids.
Bednarczyk K; Gawin M; Chekan M; Kurczyk A; Mrukwa G; Pietrowska M; Polanska J; Widlak P
J Mol Histol; 2019 Feb; 50(1):1-10. PubMed ID: 30390197
[TBL] [Abstract][Full Text] [Related]
19. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
Buergy D; Weber T; Maurer GD; Mudduluru G; Medved F; Leupold JH; Brauckhoff M; Post S; Dralle H; Allgayer H
Int J Cancer; 2009 Aug; 125(4):894-901. PubMed ID: 19480010
[TBL] [Abstract][Full Text] [Related]
20. Analytical Performance of a Gene Expression Classifier for Medullary Thyroid Carcinoma.
Pankratz DG; Hu Z; Kim SY; Monroe RJ; Wong MG; Traweek ST; Kloos RT; Walsh PS; Kennedy GC
Thyroid; 2016 Nov; 26(11):1573-1580. PubMed ID: 27605259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
